Study Highlights:

  • Adults with high blood pressure are estimated to pay almost $2,000 more in annual healthcare costs compared to those without high blood pressure.
  • Nationally, annual healthcare costs for the U.S. population with high blood pressure are estimated to be $131 billion higher compared to those without the disease.

Embargoed until 4 a.m. CT / 5 a.m. ET Wednesday, May 30, 2018

DALLAS, May 30, 2018 — Adults with high blood pressure face $1,920 higher healthcare costs each year compared to those without high blood pressure, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.

Based on the U.S. prevalence of hypertension, researchers estimate the national adjusted annual cost for the adult population with high blood pressure to be $131 billion higher compared to those without the disease.

It is important to note that this twelve-year study was done using previous hypertension guidelines – which defined high blood pressure as 140/90 mm Hg or higher. In 2017, the American Heart Association and the American College of Cardiology lowered the definition of high blood pressure to 130/80 mm Hg or higher.

“The new lower definition of high blood pressure will increase the number of adults in the hypertensive population,” said study lead author Elizabeth B. Kirkland, M.D., M.S.C.R., an assistant professor of internal medicine at Medical University of South Carolina in Charleston. “This may decrease the average cost of hypertension for individual patients while increasing the overall societal costs of hypertension.”

For this study, researchers used 2003-2014 Medical Expenditure Panel Survey (MEPS) data that included 224,920 adults, of whom 36.9 percent had high blood pressure, to measure trends and calculate estimated annual healthcare costs. Researchers adjusted for other medical reasons, such as a history of stroke or diabetes, that would contribute to their medical expenses.

Compared to patients without high blood pressure, those with high blood pressure had:

  • 2.5 times the inpatient costs;
  • almost double the outpatient costs; and
  • nearly triple the prescription medication expenditures.

“While the increased cost for patients with high blood pressure remained stable from 2003-2014, the rising prevalence of hypertension will become an increasingly large burden on the U.S. population for hypertension expenditures,” Kirkland said. “The better we can learn to recognize high blood pressure, treat it and manage it, the better we'll be able to address these costs.”

Although expenditures were higher for inpatient and outpatient care, over the course of the study period, the researchers observed a shift toward more cost in the outpatient setting than the inpatient setting, which may reflect a larger societal trend to try to bring care out of the hospital system and into locations that are more accessible to most patients, Kirkland said.

National statistics from the 2017 hypertension guidelines estimate that 46 percent of U.S. adults — 103 million people — have high blood pressure, but only about half of those have their blood pressure controlled despite improvements in diagnosing, treating and controlling hypertension.

Co-authors are Marc Heincelman, M.D.; Kinfe G. Bishu, Ph.D.; Samuel O. Schumann, M.D., M.S.C.R.; Andrew Schreiner, M.D., M.S.C.R.; R. Neal Axon, M.D., M.S.C.R.; Patrick D. Mauldin, Ph.D.; and William P. Moran, M.D., M.S. Author disclosures are on the manuscript.

Additional Resources:


Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at

About the American Heart Association

The American Heart Association is devoted to saving people from heart disease and stroke – the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit or call any of our offices around the country. Follow us on Facebook and Twitter.

For Media Inquiries and AHA/ASA Spokesperson Perspective: 214-706-1173

Karen Astle: 214-706-1392;

For Public Inquiries: 1-800-AHA-USA1 (242-8721) and